Parneet Kaur
Podiatrist · Binghamton, NYNPI 1528696812
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $10,639 of the $13,945 with a category attached, or 76.3%. 9 manufacturers reported payments, led by Evolution Surgical, Inc at 36.5% of the total. Reporting peaked in 2023 at $7,456 and has fallen 81.6% since, to $1,371 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $142.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evolution Surgical, Inc$5K
- Arthrex$3K
- Paragon 28, Inc.$3K
- Orthofix Medical, Inc.$2K
- Stryker$152
- Johnson & Johnson$96
- plus $73 from 3 others
What the payments were for
- Travel & lodging$10,63976%
- Food & beverage$3,30624%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Evolution Surgical, Inc | 16 | $5,095 |
| Arthrex | 38 | $3,351 |
| Paragon 28, Inc. | 19 | $2,886 |
| Orthofix Medical, Inc. | 19 | $2,292 |
| Stryker | 2 | $152 |
| Johnson & Johnson | 1 | $96 |
| AbbVie | 1 | $28 |
| Treace Medical Concepts, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$3,519
- Portfolio$2,228
- MONKEY RINGS$228
How this compares
$13,945 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 30 | $377 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $306 |
| Pregabalin | 12 | $294 |
| Doxycycline Hyclate | 13 | $151 |
| Methylprednisolone | 24 | $105 |
| Cephalexin | 19 | $103 |
| Ondansetron Hcl | 13 | $52 |
| Naproxen | 12 | $45 |
| Meloxicam | 11 | $39 |
| Allopurinol | 16 | $39 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Binghamton
- Jennifer SweetBinghamton$24K
- Angela FreemanBinghamton$15K
- Bradley HartBinghamton$13K
- Shari NicholsBinghamton$13K
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.